Sucralfate Oral Suspension

Brand(s)
Carafate
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Aptalis Pharma Inc. (2014-04-24)
Oldest Current Product
1993-12-16
License(s)
NDA
RxNORM
ORAL SUSPENSION\SUCRALFATE
FDAOB
ORAL\SUSPENSION\SUCRALFATE
SPL Active
ORAL\SUSPENSION\SUCRALFATE
SPL Moiety
ORAL\SUSPENSION\SUCRALFATE

product(s) by strength(s)

sucralfate 100 mg/ml oral suspension

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1589140170CarafateNDAAptalis Pharma Inc.1993-12-16SUCRALFATEORALSUSPENSIONNDA0191830fb67b1c-b4c0-46f2-8a81-df1510e006aa

relabeler product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formequivalent productapplicationspl
1001210747NDAPharmaceutical Associates, Inc.2009-11-19SUCRALFATEORALSUSPENSION589140170NDA019183fa6e4661-1bee-4a64-b982-9d44dbdb8498
2548683735CarafateNDAPhysicians Total Care, Inc.1996-03-12SUCRALFATEORALSUSPENSION589140170NDA0191830bd18d2a-07b3-4155-b08a-bdd0cfd0bd2e
3548685299NDAPhysicians Total Care, Inc.2005-05-24SUCRALFATEORALSUSPENSION589140170NDA019183187ce680-e3de-45cb-98f3-96e069804c62
4551544057NDACardinal Health2012-08-16SUCRALFATEORALSUSPENSION666890790NDA019183d72083ee-abaf-4f27-bd4c-d67ddbff4e67
5551549432NDACardinal Health2009-11-19SUCRALFATEORALSUSPENSION001210747NDA019183944fa24b-29dd-479e-8aad-a5fcbde68dfa
6666890790NDAVistapharm Inc.2012-08-16SUCRALFATEORALSUSPENSION589140170NDA019183ccc083ac-8563-4c32-8bcd-c1b12270b1ad
7680940171NDAPrecision Dose Inc.2003-08-21SUCRALFATEORALSUSPENSION589140170NDA01918323e8fee2-0bdd-466e-8233-17a3e5867956

application(s)

#idtitleapplicantapprovedapproved drug
1NDA019183CARAFATEFOREST LABORATORIES INC1993-12-16NDA019183_001

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldapprovedapplication
1NDA019183_001RXSUCRALFATE (1GM/10ML)ORALSUSPENSIONTrue1993-12-16CARAFATE

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
10bd18d2a-07b3-4155-b08a-bdd0cfd0bd2e (view SPL)CARAFATE (sucralfate) SuspensionprescriptionHuman PrescriptionPhysicians Total Care, Inc.relabel2013-03-082548683735
20fb67b1c-b4c0-46f2-8a81-df1510e006aa (view SPL)CARAFATE (sucralfate) SuspensionprescriptionHuman PrescriptionAptalis Pharma Inc.MANUFACTURE, analysis, pack2014-04-248589140170
3187ce680-e3de-45cb-98f3-96e069804c62 (view SPL)SUCRALFATE SUSPENSION1 g/10 mLprescriptionHuman PrescriptionPhysicians Total Care, Inc.relabel2010-11-241548685299
423e8fee2-0bdd-466e-8233-17a3e5867956 (view SPL)SUCRALFATE SUSPENSION1 g/10 mLprescriptionHuman PrescriptionPrecision Dose Inc.2012-02-272680940171
5944fa24b-29dd-479e-8aad-a5fcbde68dfa (view SPL)Sucralfate SuspensionprescriptionHuman PrescriptionCardinal HealthREPACK2015-01-124551549432
6ccc083ac-8563-4c32-8bcd-c1b12270b1ad (view SPL)Sucralfate Suspension 1 g/ 10 mLprescriptionHuman PrescriptionVistapharm Inc.ANALYSIS, REPACK2012-08-221666890790
7d72083ee-abaf-4f27-bd4c-d67ddbff4e67 (view SPL)Sucralfate Suspension 1 g/ 10 mLprescriptionHuman PrescriptionCardinal HealthREPACK2014-02-061551544057
8fa6e4661-1bee-4a64-b982-9d44dbdb8498 (view SPL)Sucralfate SuspensionprescriptionHuman PrescriptionPharmaceutical Associates, Inc.MANUFACTURE, REPACK2009-11-192001210747

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII